Coldstream Laboratories Names Director of Formulation Development

Adrian Raiche, Ph.D. Named as Director of Formulation Development at Coldstream Laboratories, Inc.

(firmenpresse) - LEXINGTON, KY -- (Marketwired) -- 11/18/13 -- Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has joined the company as Director of Formulation Development.

In this position, Dr. Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization and scale-up activities for manufacturing in the company's sterile manufacturing facility.

Dr. Raiche brings to Coldstream expertise in numerous aspects of pharmaceutical development, particularly lyophilization and potent compound handling. Most recently, he served as Manager of Pharmaceutical Development at Summit Biosciences contributing to formulation, analytical and process development of nasal spray products. Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals and Bausch and Lomb. Dr. Raiche holds a Ph.D. in Biomedical Engineering, a Master of Science in Biomedical Engineering, and a Bachelor of Science in Chemical Engineering, all from the University of Kentucky.

"We are pleased with Dr. Raiche's addition to the Coldstream team," said Coldstream President and CEO Eric Smart. "His knowledge of process and product development enhances Coldstream's focus on the development of parenterals, especially our emphasis on highly active compounds."

Coldstream Laboratories, Inc., based in Lexington, KY, is a privately held specialty pharmaceutical contract manufacturing organization. Coldstream operates Kentucky's only parenteral manufacturing facility.

For more information, visit or email .





Contact:
Kathy Sue Bennett
Tel: 859.977.8540
Email:

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 18.11.2013 - 16:05 Uhr
Sprache: Deutsch
News-ID 317696
Anzahl Zeichen: 0

contact information:
Town:

LEXINGTON, KY

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 282 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Coldstream Laboratories Names Director of Formulation Development"
steht unter der journalistisch-redaktionellen Verantwortung von

Coldstream Laboratories (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Coldstream Laboratories Awarded 5-Year Contract With the National Cancer Institu ...

LEXINGTON, KY -- (Marketwired) -- 09/24/13 -- Laboratories, Inc., a provider of sterile drug product and services, has announced that they have been awarded a 5-year contract with the National Cancer Institute ("NCI") under solicitation ...

Coldstream Laboratories Expands Business Development Group ...

LEXINGTON, KY -- (Marketwired) -- 09/17/13 -- Laboratories, Inc., a provider of and sterile drug product development services, has announced that Pamela Savoy has joined the company as Director of Business Development. In this position, Ms. Savoy ...

Eric Smart Named President and CEO of Coldstream Laboratories Inc. ...

LEXINGTON, KY -- (Marketwire) -- 10/29/12 -- Eric W. Smart has been named the new President and CEO of , the largest sterile pharmaceutical manufacturing facility in Kentucky.Smart brings to Coldstream over 20 years of leadership experience in the a ...

Alle Meldungen von Coldstream Laboratories